Infagel - instructions for use, reviews, analogs and forms of release (gel or ointment) of the drug for the treatment and prevention of influenza, ARVI, herpes, chickenpox in adults, children and pregnancy. Composition

In this article, you can read the instructions for using the drug Infagel. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of physicians specialists on the use of Infagel in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Infagel in the presence of existing structural analogs. Use for the treatment and prevention of influenza, SARS, herpes, chickenpox in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

Infagel - has a wide spectrum of antiviral activity, bacteriostatic and anti-inflammatory action, as well as antitumor and immunomodulating activity.

Composition

Human recombinant Interferon alfa-2b + excipients.

Indications

• treatment of herpetic lesions of the skin and mucous membranes: simple and herpes zoster, chicken pox; recurrent herpes of the face, genitals, gingivitis, herpetic stomatitis;
• prevention of influenza and ARVI in adults who had contact with patients with influenza and ARVI.

Forms of release

Gel for local and external use (sometimes mistakenly called ointment).

Other dosage forms, be it tablets or capsules, did not exist in the Directory at the time of publication of the drug.

Instructions for use and how to use them

In the treatment of herpetic lesions, the gel is applied to the affected skin and mucous membranes with a thin layer 2 times a day at intervals of 12 hours and dried for 10-15 minutes to form a protective film. The duration of the course of treatment is from 3 to 5 days, until the integrity of the skin and mucous membranes have completely disappeared.

For the prevention of influenza and SARS in periods of rising morbidity, the drug is applied to the mucosa of the nasal passages 2 times a day at intervals of 12 h during the first and third weeks of the course, in the second week they take a break.

Side effect

Side effect of the drug is not noted.

Contraindications

• allergic diseases in the acute stage.

Application in pregnancy and lactation

Not indicated.

Use in children

Not indicated.

special instructions

The drug should be stored in a place protected from light, inaccessible to children at a temperature of 0 to 10 degrees Celsius. Shelf life - 2 years.

The drug with expired shelf life is not subject to application.

The drug is approved for use as a means of OTC.

Drug Interactions

For the treatment of infectious and inflammatory and viral diseases, the drug can be used in combination therapy with antibacterial drugs, glucocorticoids, interferon inducers and antiviral drugs.

Analogues of the drug Infagel

Structural analogs for the active substance:

• Inter;
• Reaferon EU Lipint;
• Roferon A.

Analogues for the pharmacological group (interferons):

• Avonex;
• Algeron;
• Altevir;
• Alfaron;
• Alfaferon;
• Betaferon;
• Vagiphereon;
• Viferon;
• Wallferon;
• Genfaxon;
• Genferon;
• Genferon Light;
• Herpferon;
• Hyaferon;
• Grippferon;
• Ingaron;
• Inter;
• Interferal;
• Interferon human leukocyte;
• Intron A;
• Inferon;
• Infibet;
• Kipferon;
• Layfferon;
• Lokferon;
• Ophthalmoferon;
• PegAtlevir;
• Pegasys;
• Pegylated interferon alfa-2b;
• PegIntron;
• Realdiron;
• Reaferon EU Lipint;
• Rebif;
• Ronbetal;
• Roferon A;
• SynnoWex;
• Extavia.

Similar medicines:

Other medicines: